SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Emec who wrote (1097)10/7/1998 12:33:00 PM
From: jake burns   of 1510
 
Interesting post on Yahoo from Padre Mulcahy. He says that IMNR cancelled a road show and speculated that it was due to Rheumatoid Arthritis data/corporate collaboration. Although I don't see that connection, I can think of other scenarios (dupont/agph/imnr merger) which would obviate the need to raise institutional interest. Of course, the real reason is probably just that IMNR is too busy right now with all the phase 2 remune and ra studies coming down the pike, but it's fun to speculate. By the way, I wouldn't ever make a good rocket scientist...i'm not smart enough:-)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News